![Quiver Logo](/static/img/logo-icon.png)
![LTRN logo](https://quiver-logos.s3.us-east-2.amazonaws.com/ltrn.png)
Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LTRN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of LTRN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LTRN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to LTRN
Recent picks made for LTRN stock on CNBC
ETFs with the largest estimated holdings in LTRN
Flights by private jets registered to LTRN
![Quiver Logo](/static/img/logo-icon.png)